nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—SLC15A1—Ramipril—type 1 diabetes mellitus	0.657	1	CbGbCtD
L-DOPA—Pemphigus—Ramipril—type 1 diabetes mellitus	0.0123	0.132	CcSEcCtD
L-DOPA—DDC—nerve—type 1 diabetes mellitus	0.00775	0.0922	CbGeAlD
L-DOPA—DRD1—nerve—type 1 diabetes mellitus	0.00569	0.0677	CbGeAlD
L-DOPA—PSIP1—retina—type 1 diabetes mellitus	0.00563	0.067	CbGeAlD
L-DOPA—PSIP1—nephron tubule—type 1 diabetes mellitus	0.0053	0.0631	CbGeAlD
L-DOPA—PSIP1—cardiovascular system—type 1 diabetes mellitus	0.00476	0.0566	CbGeAlD
L-DOPA—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.00474	0.0509	CcSEcCtD
L-DOPA—SLC7A8—islet of Langerhans—type 1 diabetes mellitus	0.00434	0.0516	CbGeAlD
L-DOPA—PSIP1—lymphoid tissue—type 1 diabetes mellitus	0.004	0.0476	CbGeAlD
L-DOPA—SLC7A8—nephron tubule—type 1 diabetes mellitus	0.00349	0.0416	CbGeAlD
L-DOPA—DRD2—nerve—type 1 diabetes mellitus	0.00336	0.04	CbGeAlD
L-DOPA—SLC7A5—islet of Langerhans—type 1 diabetes mellitus	0.00336	0.04	CbGeAlD
L-DOPA—SLC7A8—kidney—type 1 diabetes mellitus	0.00307	0.0365	CbGeAlD
L-DOPA—SLC7A8—pancreas—type 1 diabetes mellitus	0.00305	0.0363	CbGeAlD
L-DOPA—DDC—nephron tubule—type 1 diabetes mellitus	0.00302	0.036	CbGeAlD
L-DOPA—SLC7A5—retina—type 1 diabetes mellitus	0.00287	0.0342	CbGeAlD
L-DOPA—SLC7A5—nephron tubule—type 1 diabetes mellitus	0.00271	0.0322	CbGeAlD
L-DOPA—DDC—kidney—type 1 diabetes mellitus	0.00266	0.0316	CbGeAlD
L-DOPA—SLC7A5—cardiovascular system—type 1 diabetes mellitus	0.00243	0.0289	CbGeAlD
L-DOPA—SLC7A5—pancreas—type 1 diabetes mellitus	0.00236	0.0281	CbGeAlD
L-DOPA—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00229	0.0246	CcSEcCtD
L-DOPA—SLC15A1—nephron tubule—type 1 diabetes mellitus	0.00225	0.0267	CbGeAlD
L-DOPA—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00223	0.0239	CcSEcCtD
L-DOPA—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.00219	0.0261	CbGeAlD
L-DOPA—SLC16A10—nephron tubule—type 1 diabetes mellitus	0.00207	0.0247	CbGeAlD
L-DOPA—SLC7A5—lymphoid tissue—type 1 diabetes mellitus	0.00204	0.0243	CbGeAlD
L-DOPA—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00198	0.0212	CcSEcCtD
L-DOPA—SLC15A1—kidney—type 1 diabetes mellitus	0.00197	0.0235	CbGeAlD
L-DOPA—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00191	0.0205	CcSEcCtD
L-DOPA—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0019	0.0204	CcSEcCtD
L-DOPA—Purpura—Ramipril—type 1 diabetes mellitus	0.00178	0.0191	CcSEcCtD
L-DOPA—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.0017	0.0182	CcSEcCtD
L-DOPA—Isoetarine—ADRB1—type 1 diabetes mellitus	0.00168	0.225	CrCbGaD
L-DOPA—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.0016	0.0172	CcSEcCtD
L-DOPA—Norepinephrine—SLC18A2—type 1 diabetes mellitus	0.00159	0.213	CrCbGaD
L-DOPA—SLC16A10—lymphoid tissue—type 1 diabetes mellitus	0.00156	0.0186	CbGeAlD
L-DOPA—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00156	0.0168	CcSEcCtD
L-DOPA—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00154	0.0165	CcSEcCtD
L-DOPA—Gastritis—Ramipril—type 1 diabetes mellitus	0.00152	0.0163	CcSEcCtD
L-DOPA—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00148	0.0159	CcSEcCtD
L-DOPA—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00144	0.0155	CcSEcCtD
L-DOPA—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00144	0.0155	CcSEcCtD
L-DOPA—DRD2—retina—type 1 diabetes mellitus	0.00139	0.0166	CbGeAlD
L-DOPA—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00138	0.0148	CcSEcCtD
L-DOPA—Weight increased—Ramipril—type 1 diabetes mellitus	0.00135	0.0145	CcSEcCtD
L-DOPA—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.0013	0.014	CcSEcCtD
L-DOPA—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00129	0.0139	CcSEcCtD
L-DOPA—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00129	0.0139	CcSEcCtD
L-DOPA—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.00128	0.0138	CcSEcCtD
L-DOPA—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00123	0.0132	CcSEcCtD
L-DOPA—Flushing—Ramipril—type 1 diabetes mellitus	0.0011	0.0118	CcSEcCtD
L-DOPA—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00106	0.0114	CcSEcCtD
L-DOPA—Alopecia—Ramipril—type 1 diabetes mellitus	0.00105	0.0112	CcSEcCtD
L-DOPA—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00104	0.0111	CcSEcCtD
L-DOPA—Tension—Ramipril—type 1 diabetes mellitus	0.00101	0.0109	CcSEcCtD
L-DOPA—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00101	0.0108	CcSEcCtD
L-DOPA—Nervousness—Ramipril—type 1 diabetes mellitus	0.001	0.0107	CcSEcCtD
L-DOPA—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000992	0.0106	CcSEcCtD
L-DOPA—Tremor—Ramipril—type 1 diabetes mellitus	0.000966	0.0104	CcSEcCtD
L-DOPA—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000957	0.0103	CcSEcCtD
L-DOPA—Agitation—Ramipril—type 1 diabetes mellitus	0.000948	0.0102	CcSEcCtD
L-DOPA—Angioedema—Ramipril—type 1 diabetes mellitus	0.000943	0.0101	CcSEcCtD
L-DOPA—Malaise—Ramipril—type 1 diabetes mellitus	0.00093	0.00998	CcSEcCtD
L-DOPA—Syncope—Ramipril—type 1 diabetes mellitus	0.000925	0.00992	CcSEcCtD
L-DOPA—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000923	0.00991	CcSEcCtD
L-DOPA—Palpitations—Ramipril—type 1 diabetes mellitus	0.000912	0.00978	CcSEcCtD
L-DOPA—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000907	0.00973	CcSEcCtD
L-DOPA—Cough—Ramipril—type 1 diabetes mellitus	0.0009	0.00966	CcSEcCtD
L-DOPA—Convulsion—Ramipril—type 1 diabetes mellitus	0.000894	0.00959	CcSEcCtD
L-DOPA—Chest pain—Ramipril—type 1 diabetes mellitus	0.000878	0.00942	CcSEcCtD
L-DOPA—Anxiety—Ramipril—type 1 diabetes mellitus	0.000875	0.00939	CcSEcCtD
L-DOPA—Discomfort—Ramipril—type 1 diabetes mellitus	0.000868	0.00931	CcSEcCtD
L-DOPA—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000859	0.00921	CcSEcCtD
L-DOPA—Confusional state—Ramipril—type 1 diabetes mellitus	0.000849	0.00911	CcSEcCtD
L-DOPA—Oedema—Ramipril—type 1 diabetes mellitus	0.000842	0.00903	CcSEcCtD
L-DOPA—Shock—Ramipril—type 1 diabetes mellitus	0.000828	0.00889	CcSEcCtD
L-DOPA—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000824	0.00884	CcSEcCtD
L-DOPA—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000814	0.00873	CcSEcCtD
L-DOPA—Anorexia—Ramipril—type 1 diabetes mellitus	0.000802	0.00861	CcSEcCtD
L-DOPA—Hypotension—Ramipril—type 1 diabetes mellitus	0.000787	0.00844	CcSEcCtD
L-DOPA—Droxidopa—ADRB1—type 1 diabetes mellitus	0.000768	0.103	CrCbGaD
L-DOPA—Insomnia—Ramipril—type 1 diabetes mellitus	0.000761	0.00817	CcSEcCtD
L-DOPA—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000756	0.00811	CcSEcCtD
L-DOPA—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000751	0.00805	CcSEcCtD
L-DOPA—Somnolence—Ramipril—type 1 diabetes mellitus	0.000748	0.00803	CcSEcCtD
L-DOPA—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000741	0.00795	CcSEcCtD
L-DOPA—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000732	0.00785	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000727	0.0078	CcSEcCtD
L-DOPA—Fatigue—Ramipril—type 1 diabetes mellitus	0.000726	0.00779	CcSEcCtD
L-DOPA—Constipation—Ramipril—type 1 diabetes mellitus	0.00072	0.00772	CcSEcCtD
L-DOPA—Isoprenaline—ADRB1—type 1 diabetes mellitus	0.000699	0.0933	CrCbGaD
L-DOPA—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000694	0.00744	CcSEcCtD
L-DOPA—CYP2D6—kidney—type 1 diabetes mellitus	0.000693	0.00824	CbGeAlD
L-DOPA—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000688	0.00739	CcSEcCtD
L-DOPA—Urticaria—Ramipril—type 1 diabetes mellitus	0.000669	0.00718	CcSEcCtD
L-DOPA—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000666	0.00714	CcSEcCtD
L-DOPA—Norepinephrine—ADRB1—type 1 diabetes mellitus	0.000647	0.0864	CrCbGaD
L-DOPA—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00062	0.00665	CcSEcCtD
L-DOPA—Asthenia—Ramipril—type 1 diabetes mellitus	0.000604	0.00648	CcSEcCtD
L-DOPA—Dopamine—ADRB1—type 1 diabetes mellitus	0.000601	0.0803	CrCbGaD
L-DOPA—Pruritus—Ramipril—type 1 diabetes mellitus	0.000596	0.00639	CcSEcCtD
L-DOPA—Epinephrine—ADRB1—type 1 diabetes mellitus	0.000587	0.0784	CrCbGaD
L-DOPA—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000576	0.00618	CcSEcCtD
L-DOPA—Epinephrine—TNF—type 1 diabetes mellitus	0.000557	0.0744	CrCbGaD
L-DOPA—Dizziness—Ramipril—type 1 diabetes mellitus	0.000557	0.00597	CcSEcCtD
L-DOPA—Vomiting—Ramipril—type 1 diabetes mellitus	0.000535	0.00574	CcSEcCtD
L-DOPA—Rash—Ramipril—type 1 diabetes mellitus	0.000531	0.00569	CcSEcCtD
L-DOPA—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00053	0.00569	CcSEcCtD
L-DOPA—Headache—Ramipril—type 1 diabetes mellitus	0.000527	0.00566	CcSEcCtD
L-DOPA—Nausea—Ramipril—type 1 diabetes mellitus	0.0005	0.00537	CcSEcCtD
L-DOPA—Liothyronine—ALB—type 1 diabetes mellitus	0.000352	0.0471	CrCbGaD
L-DOPA—DRD5—Signaling Pathways—APOC3—type 1 diabetes mellitus	5.75e-05	0.000364	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IAPP—type 1 diabetes mellitus	5.75e-05	0.000364	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	5.75e-05	0.000364	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—SST—type 1 diabetes mellitus	5.68e-05	0.00036	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	5.65e-05	0.000358	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—GCG—type 1 diabetes mellitus	5.62e-05	0.000356	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—SST—type 1 diabetes mellitus	5.6e-05	0.000355	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	5.58e-05	0.000353	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—GCG—type 1 diabetes mellitus	5.57e-05	0.000353	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—CCR5—type 1 diabetes mellitus	5.51e-05	0.000349	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—GCG—type 1 diabetes mellitus	5.5e-05	0.000348	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GAL—type 1 diabetes mellitus	5.44e-05	0.000344	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.44e-05	0.000344	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	5.43e-05	0.000344	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	5.41e-05	0.000343	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—CCR5—type 1 diabetes mellitus	5.38e-05	0.000341	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	5.38e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL11—type 1 diabetes mellitus	5.38e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCL20—type 1 diabetes mellitus	5.38e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	5.36e-05	0.00034	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	5.29e-05	0.000335	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—VAV1—type 1 diabetes mellitus	5.26e-05	0.000333	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	5.24e-05	0.000332	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	5.22e-05	0.000331	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	5.21e-05	0.00033	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	5.2e-05	0.000329	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	5.14e-05	0.000326	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	5.13e-05	0.000325	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—GCG—type 1 diabetes mellitus	5.06e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CHRM2—type 1 diabetes mellitus	5.05e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SST—type 1 diabetes mellitus	5.05e-05	0.00032	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—IL6—type 1 diabetes mellitus	5.03e-05	0.000319	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ADRB1—type 1 diabetes mellitus	5.03e-05	0.000318	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—GCG—type 1 diabetes mellitus	4.99e-05	0.000316	CbGpPWpGaD
L-DOPA—PSIP1—Disease—IL6—type 1 diabetes mellitus	4.93e-05	0.000312	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GAL—type 1 diabetes mellitus	4.89e-05	0.00031	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	4.88e-05	0.000309	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	4.87e-05	0.000308	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL20—type 1 diabetes mellitus	4.84e-05	0.000306	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCL11—type 1 diabetes mellitus	4.84e-05	0.000306	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GAL—type 1 diabetes mellitus	4.83e-05	0.000306	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	4.81e-05	0.000304	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL20—type 1 diabetes mellitus	4.77e-05	0.000302	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCL11—type 1 diabetes mellitus	4.77e-05	0.000302	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	4.73e-05	0.0003	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—SST—type 1 diabetes mellitus	4.72e-05	0.000299	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	4.72e-05	0.000299	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	4.7e-05	0.000298	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—VAV1—type 1 diabetes mellitus	4.67e-05	0.000296	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	4.65e-05	0.000295	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	4.55e-05	0.000288	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ITPR3—type 1 diabetes mellitus	4.54e-05	0.000287	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—IL6—type 1 diabetes mellitus	4.53e-05	0.000287	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GCG—type 1 diabetes mellitus	4.5e-05	0.000285	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CHRM2—type 1 diabetes mellitus	4.49e-05	0.000284	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	4.48e-05	0.000283	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—IL6—type 1 diabetes mellitus	4.47e-05	0.000283	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	4.41e-05	0.000279	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.33e-05	0.000274	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—SST—type 1 diabetes mellitus	4.29e-05	0.000271	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SH2B3—type 1 diabetes mellitus	4.27e-05	0.00027	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	4.27e-05	0.00027	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—APOC3—type 1 diabetes mellitus	4.24e-05	0.000269	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IAPP—type 1 diabetes mellitus	4.24e-05	0.000269	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	4.21e-05	0.000266	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.21e-05	0.000266	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.19e-05	0.000266	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	4.08e-05	0.000259	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—CCR5—type 1 diabetes mellitus	4.06e-05	0.000257	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	4.05e-05	0.000256	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	4.03e-05	0.000255	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	4.03e-05	0.000255	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	4.01e-05	0.000254	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.98e-05	0.000252	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.97e-05	0.000251	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	3.96e-05	0.00025	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	3.93e-05	0.000249	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	3.92e-05	0.000248	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3.92e-05	0.000248	CbGpPWpGaD
L-DOPA—DDC—Metabolism—INS—type 1 diabetes mellitus	3.85e-05	0.000244	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.84e-05	0.000243	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.82e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—GCG—type 1 diabetes mellitus	3.82e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.82e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.82e-05	0.000242	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.81e-05	0.000241	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	3.79e-05	0.00024	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IAPP—type 1 diabetes mellitus	3.77e-05	0.000239	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOC3—type 1 diabetes mellitus	3.77e-05	0.000239	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SST—type 1 diabetes mellitus	3.73e-05	0.000236	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	3.72e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.71e-05	0.000235	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GAL—type 1 diabetes mellitus	3.69e-05	0.000234	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	3.68e-05	0.000233	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CD86—type 1 diabetes mellitus	3.67e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.66e-05	0.000232	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL11—type 1 diabetes mellitus	3.65e-05	0.000231	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCL20—type 1 diabetes mellitus	3.65e-05	0.000231	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	3.61e-05	0.000229	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.61e-05	0.000228	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	3.57e-05	0.000226	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	3.56e-05	0.000226	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	3.56e-05	0.000225	CbGpPWpGaD
L-DOPA—DDC—Metabolism—ALB—type 1 diabetes mellitus	3.53e-05	0.000223	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	3.5e-05	0.000222	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.48e-05	0.00022	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	3.43e-05	0.000218	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—type 1 diabetes mellitus	3.42e-05	0.000217	CbGpPWpGaD
L-DOPA—DDC—Metabolism—NOS3—type 1 diabetes mellitus	3.37e-05	0.000214	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SST—type 1 diabetes mellitus	3.35e-05	0.000212	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.34e-05	0.000211	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GCG—type 1 diabetes mellitus	3.32e-05	0.00021	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SST—type 1 diabetes mellitus	3.31e-05	0.00021	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.31e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	3.29e-05	0.000209	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.25e-05	0.000206	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	3.22e-05	0.000204	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.21e-05	0.000203	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	3.2e-05	0.000202	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.18e-05	0.000201	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—VAV1—type 1 diabetes mellitus	3.1e-05	0.000197	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CXCL10—type 1 diabetes mellitus	3.1e-05	0.000196	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	3.08e-05	0.000195	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	3.04e-05	0.000193	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	3e-05	0.00019	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	2.99e-05	0.000189	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GCG—type 1 diabetes mellitus	2.95e-05	0.000187	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.9e-05	0.000184	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.88e-05	0.000183	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.88e-05	0.000183	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.88e-05	0.000182	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.84e-05	0.00018	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.82e-05	0.000179	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.81e-05	0.000178	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.79e-05	0.000177	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.79e-05	0.000176	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	2.76e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.76e-05	0.000175	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.75e-05	0.000174	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	2.72e-05	0.000172	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CD86—type 1 diabetes mellitus	2.71e-05	0.000171	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CD80—type 1 diabetes mellitus	2.68e-05	0.000169	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.59e-05	0.000164	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.57e-05	0.000163	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	2.55e-05	0.000161	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.54e-05	0.000161	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SST—type 1 diabetes mellitus	2.53e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.53e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—INS—type 1 diabetes mellitus	2.53e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	2.52e-05	0.00016	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.51e-05	0.000159	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.5e-05	0.000158	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.45e-05	0.000155	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.44e-05	0.000155	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	2.44e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.43e-05	0.000154	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD86—type 1 diabetes mellitus	2.4e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.4e-05	0.000152	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.37e-05	0.00015	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.35e-05	0.000149	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.33e-05	0.000147	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.31e-05	0.000146	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	2.3e-05	0.000145	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—E2F1—type 1 diabetes mellitus	2.28e-05	0.000144	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	2.26e-05	0.000143	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.22e-05	0.00014	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.2e-05	0.000139	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.17e-05	0.000138	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	2.17e-05	0.000137	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.16e-05	0.000137	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	2.15e-05	0.000136	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCR5—type 1 diabetes mellitus	2.13e-05	0.000135	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.13e-05	0.000135	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.11e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.11e-05	0.000134	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.1e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	2.1e-05	0.000133	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—type 1 diabetes mellitus	2.09e-05	0.000132	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	2.02e-05	0.000128	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	2.01e-05	0.000127	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.98e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.97e-05	0.000125	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.92e-05	0.000121	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.91e-05	0.000121	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.88e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—type 1 diabetes mellitus	1.88e-05	0.000119	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.87e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—INS—type 1 diabetes mellitus	1.87e-05	0.000118	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.84e-05	0.000117	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.8e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.8e-05	0.000114	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	1.78e-05	0.000113	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.76e-05	0.000111	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CD80—type 1 diabetes mellitus	1.75e-05	0.000111	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.75e-05	0.000111	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	1.68e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.67e-05	0.000106	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.66e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—INS—type 1 diabetes mellitus	1.66e-05	0.000105	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.64e-05	0.000104	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.63e-05	0.000103	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.62e-05	0.000103	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.62e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.61e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.6e-05	0.000102	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.6e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.6e-05	0.000101	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.58e-05	0.0001	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.57e-05	9.97e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.5e-05	9.5e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.48e-05	9.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.47e-05	9.33e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.45e-05	9.2e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.44e-05	9.1e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.39e-05	8.8e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	1.39e-05	8.78e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.38e-05	8.74e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	1.34e-05	8.5e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	1.33e-05	8.44e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	1.27e-05	8.03e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.25e-05	7.92e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.25e-05	7.91e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.24e-05	7.87e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.23e-05	7.81e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	1.23e-05	7.8e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.23e-05	7.77e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.23e-05	7.76e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.22e-05	7.73e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.17e-05	7.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.13e-05	7.18e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.11e-05	7.04e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	1.1e-05	7e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.06e-05	6.72e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.05e-05	6.65e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.04e-05	6.57e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.55e-06	6.05e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.44e-06	5.98e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	9.43e-06	5.97e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.42e-06	5.97e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.38e-06	5.94e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	8.85e-06	5.6e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	8.15e-06	5.16e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	8.11e-06	5.14e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.93e-06	5.02e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	7.76e-06	4.91e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	7.34e-06	4.65e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	7.24e-06	4.59e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.21e-06	4.57e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	5.54e-06	3.51e-05	CbGpPWpGaD
